Search
News Archive
Categories
Archive for September, 2011
Aurora Algae Raises $22 Million in Funding Round
Posted On: September 4, 2011Aurora Algae, with dual operations in Hayward, CA and Karratha, Australia, has received a round of $22 million from Oak Investment Partners, other existing investors, and a large foreign strategic investor who, at this time, has not been identified.
The funding will help Aurora execute plans for the construction of its commercial facility in Maitland, Western Australia — for which the company secured 610 hectares (approximately 1500 acres) of land earlier this year — and expand operations within its Hayward (CA) and Karratha (Western Australia) facilities. They expect to break ground in Maitland early next year.
Global Glucosamine Market to Reach 46.6 Thousand Metric Tons by 2017, According to a New Report
Posted On: September 4, 2011The research report titled “Glucosamine: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the Glucosamine market, current market trends, key growth drivers, new research findings on Glucosamine, new product introductions and launches, recent corporate initiatives, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for Glucosamine for the years 2009 through 2017 for the following geographic markets – US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. The study also presents historic data for the period 2003 through 2008.
Read more
Mar. Drugs, Volume 9, Issue 8 (August 2011), Pages 1307-1439: New Issue
Posted On: September 4, 2011MDPI AG is pleased to announce the publication of the following issue:Mar. Drugs, Volume 9, Issue 8 (August 2011), Pages 1307-1439 at http://www.mdpi.com/1660-3397/9/8/
Table of Contents:
Shi-Yie Cheng, Pei-Wen Chen, Hwa-Pyng Chen, Shang-Kwei Wang and Chang-Yih Duh
Article: New Cembranolides from the Dongsha Atoll Soft Coral Lobophytum durum
Mar. Drugs 2011, 9(8), 1307-1318; doi:10.3390/md9081307
http://www.mdpi.com/1660-3397/9/81307/
Chia-Ying Kao, Jui-Hsin Su, Mei-Chin Lu, Tsong-Long Hwang, Wei-Hsien Wang, Jih-Jung Chen, Jyh-Horng Sheu, Yueh-Hsiung Kuo, Ching-Feng Weng, Lee-Shing Fang, Zhi-Hong Wen and Ping-Jyun Sung
Article: Lobocrassins A–E: New Cembrane-Type Diterpenoids from the Soft Coral Lobophytum crassum
Mar. Drugs 2011, 9(8), 1319-1331; doi:10.3390/md9081319
http://www.mdpi.com/1660-3397/9/81319/
Mariana Angelica Oliveira Bitencourt, Gracielle Rodrigues Dantas, Daysianne Pereira Lira, Jose Maria Barbosa-Filho, George Emmanuel Cavalcanti de Miranda, Barbara Viviana de Oliveira Santos and Janeusa Trindade Souto
Article: Aqueous and Methanolic Extracts of Caulerpa mexicana Suppress Cell Migration and Ear Edema Induced by Inflammatory Agents
Mar. Drugs 2011, 9(8), 1332-1345; doi:10.3390/md9081332
http://www.mdpi.com/1660-3397/9/81332/
Laura de Andrade Moura, Fredy Ortiz-Ramirez, Diana Negrao Cavalcanti, Suzi Meneses Ribeiro, Guilherme Muricy, Valeria Laneuville Teixeira and Andre Lopes Fuly
Article: Evaluation of Marine Brown Algae and Sponges from Brazil as Anticoagulant and Antiplatelet Products
Mar. Drugs 2011, 9(8), 1346-1358; doi:10.3390/md9081346
http://www.mdpi.com/1660-3397/9/81346/
Min-Kyoung Park, Uhee Jung and Changhyun Roh
Article: Fucoidan from Marine Brown Algae Inhibits Lipid Accumulation
Mar. Drugs 2011, 9(8), 1359-1367; doi:10.3390/md9081359
http://www.mdpi.com/1660-3397/9/81359/
Yi Wang, Jinkai Zheng, Peipei Liu, Wei Wang and Weiming Zhu
Communication: Three New Compounds from Aspergillus terreus PT06-2 Grown in a High Salt Medium
Mar. Drugs 2011, 9(8), 1368-1378; doi:10.3390/md9081368
http://www.mdpi.com/1660-3397/9/81368/
Ya-Nan Wang, Chang-Lun Shao, Cai-Juan Zheng, Yi-Yan Chen and Chang-Yun Wang
Article: Diversity and Antibacterial Activities of Fungi Derived from the Gorgonian Echinogorgia rebekka from the South China Sea
Mar. Drugs 2011, 9(8), 1379-1390; doi:10.3390/md9081379
http://www.mdpi.com/1660-3397/9/81379/
Anahit Penesyan, Jan Tebben, Matthew Lee, Torsten Thomas, Staffan Kjelleberg, Tilmann Harder and Suhelen Egan
Article: Identification of the Antibacterial Compound Produced by the Marine Epiphytic Bacterium Pseudovibrio sp. D323 and Related Sponge-Associated Bacteria
Mar. Drugs 2011, 9(8), 1391-1402; doi:10.3390/md9081391
http://www.mdpi.com/1660-3397/9/81391/
Cui Li, Ming-Ping La, Peng Sun, Tibor Kurtan, Attila Mandi, Hua Tang, Bao-Shu Liu, Yang-Hua Yi, Ling Li and Wen Zhang
Article: Bioactive (3Z,5E)-11,20-Epoxybriara-3,5-dien-7,18-olide Diterpenoids from the South China Sea Gorgonian Dichotella gemmacea
Mar. Drugs 2011, 9(8), 1403-1418; doi:10.3390/md9081403
http://www.mdpi.com/1660-3397/9/81403/
Takashi Maoka, Naoshige Akimoto, Miyuki Tsushima, Sadao Komemushi, Takuma Mezaki, Fumihito Iwase, Yoshimitsu Takahashi, Naomi Sameshima, Miho Mori and Yoshikazu Sakagami
Article: Carotenoids in Marine Invertebrates Living along the Kuroshio Current Coast
Mar. Drugs 2011, 9(8), 1419-1427; doi:10.3390/md9081419
http://www.mdpi.com/1660-3397/9/81419/
Sumei Li, Xinpeng Tian, Siwen Niu, Wenjun Zhang, Yuchan Chen, Haibo Zhang, Xianwen Yang, Weimin Zhang, Wenjun Li, Si Zhang, Jianhua Ju and Changsheng Zhang
Article: Pseudonocardians A–C, New Diazaanthraquinone Derivatives from a Deap-Sea Actinomycete Pseudonocardia sp. SCSIO 01299
Mar. Drugs 2011, 9(8), 1428-1439; doi:10.3390/md9081428
http://www.mdpi.com/1660-3397/9/81428/
UK University Research Group seeks SME partners to explore the development of three specific marine bio-resources to produce high value products: anti-cancer drugs, oxygenase biocatalysts, anti-microbials
Posted On: September 4, 2011The marine environment is a very rich source of bio-molecules with therapeutic applications. Blue biotechnology specifically seeks to harness the biodiversity of the marine environment for access to high-value and relatively low-volume biological products. Recent advances in molecular biology (including metagenomic methods) mean that there is now remarkable potential to harness genetic biodiversity from specific marine environments for bio-product preparation. For example, when studying marine bacteria they are no longer limited to experimental approaches that focus on the <1% of organisms that can be easily cultivated as pure cultures in the laboratory.
The valorization of marine biodiversity for the EU economy using such approaches therefore offers much promise. In this project they will aim to explore the development of three specific marine bio-resources to produce high value products:
i) Anti-cancer drugs from sponges
ii) Oxygenase biocatalysts from marine bacteria
iii) Anti-microbials based on bacterial viruses
Technical Specifications / Specific technical requirements:
Call Details: KBBE.2012.3.2-01 Innovative marine biodiscovery pipelines for novel industrial products, call deadline 15th November 2011.
Expected proposal budget around ¬5m. Funding for SMEs at 75%
Proposal under prepartion, consotrium academic members in place, SMEs being recruited.
Marine Biotechnology Center of North Carolina breaks ground this week
Posted On: September 4, 2011UNCW’s MARBIONC Center, or the Marine Biotechnology Center of North Carolina, will break ground the first week of September at the Center for Marine Science.
For students in the marine biotechnology program, this could mean big opportunities.
“Students will have the chance to do research that could result in permanent future employment,” said Dr. Jeffery Wright of the Marine Science department.
The center will also help set UNCW’s marine biotechnology students on a path for success.
“The MARBIONC will prepare students for careers in biotechnology and transform how we traditionally approach educating future marine scientists,” said Kevin Zelnio, an independent scientist and assistant editor of Deep Sea News. “It recognizes there is an industry for students that combines very useful research with a marine science education.”
Other hopes for the center include job creation and spinoff companies.
But the main goal of the center is to develop new products and commercialize them.










